Home > Insider Trading > Filing (0001607062-22-000004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615999	Neuropathix Inc.	NPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
944235	Dean Petkanas	3805 Old Easton Road Doylestown PA 18902	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-01-05	89,000	$0.05	24,770,029	No	4	S	Indirect	See Note
Common Stock	Disposition	2022-01-06	120,000	$0.05	24,650,029	No	4	S	Indirect	See Note
Common Stock	Disposition	2022-01-07	41,000	$0.05	24,609,029	No	4	S	Indirect	See Note
Common Stock	Disposition	2022-01-07	300,000	$0.00	24,309,029	No	4	G	Indirect	See Note
Common Stock	Disposition	2022-01-07	250,000	$0.00	24,059,029	No	4	G	Indirect	See Note

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Note
No	4	S	Indirect	See Note
No	4	S	Indirect	See Note
No	4	G	Indirect	See Note
No	4	G	Indirect	See Note

Footnotes

The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.
These shares were sold in multiple transactions at prices falling within those ranges set forth in footnotes (3) and (5) of this Form 4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the relevant footnotes.
These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
Represents a gift of shares by Golden Gate Capital Partners, LLC.